MEDIPOST America

MEDIPOST is a leading stem cell biotechnology company focused on developing products to meet unmet medical needs.

MEDIPOST provides services and develops products related to a readily available and non-controversial source – human umbilical cord blood and human Umbilical Cord Blood derived Mesenchymal Stem Cells (hUCB-MSCs), respectively. The stem cells, coming from unrelated healthy donors, have demonstrated the ability to regenerate and/or to recover functionality of different types of damaged tissues. Such adult stem cell therapies having an “off-the-shelf” concept revolutionize medical treatments and are bringing about a new era of mass-manufactured allogeneic stem cell drug products.